According to a new study by researchers at Yale School of Medicine, the decline in estrogen therapy that resulted after a 2002 report by Women’s Health Initiative (WHI) that cited possible dangers with the therapy may have led to 50,000 deaths to women who have had hysterectomies. Before the WHI study was released, 90 percent of women between the ages of 50 and 59 used estrogen therapy to treat menopausal symptoms. Today only 10 percent of women in this age group use Estrogen therapy.
An Overlooked Distinction That Is Causing Unneeded Deaths
The WHI study linked estrogen therapy with significant increases in breast cancer, heart disease, stroke and blood clots and made a distinction about the different results for women with and without a uterus but the public didn’t pick up on the distinction. The public viewed, in larger numbers, that estrogen therapy was bad in both cases. The WHI study said that estrogen therapy increased best cancer and other diseases because of a hormone called progestin, which is needed in conjunction with estrogen to prevent uterine cancer by women who have not had a hysterectomy. The key to the matter, and overlooked by most women, is that women with hysterectomies have no need for progestin and estrogen therapy for them remains almost completely beneficial.
Recent Finding from WHI
In 2011 and 2012 WHI reported that women who received estrogen compared to those who received placebo had fewer deaths each year for 10 years and were less likely to develop breast cancer and heart disease.
Contact us (513-985-0950) today to to get more information about Estrogen Therapy for women with hysterectomies.
See This Video of Phillip M Sarrel, Professor Emeritus Ob/Gyn & Psychiatry for Yale University…